Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Extended Pelvic Lymph Node Dissection Predicts Rehospitalization After Robot-Assisted Radical Prostatectomy

Key clinical point: Extended pelvic lymph node dissection (ePLND) is associated with the risk of hospital readmission over the long term after robot-assisted radical prostatectomy (RARP) for prostate cancer.

Major finding: Hospital readmission was detected in 25 cases (2.8%); readmission rates were higher after RARP with ePLND vs. RARP alone (4.4% vs. 0.8%). ePLND was positively associated with the risk of hospital readmission (hazard ratio, 5.935; P = .004).

Study details: The data were obtained from a retrospective study of 890 patients with prostate cancer who underwent RARP between 2013 and 2018; ePLND was performed in 495 patients.

Disclosures: The authors received no financial support and declared no conflicts of interest.

Citation:

Sebben M et al. World J Urol. 2020 Jan 24. doi: 10.1007/s00345-020-03094-2.